Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Compass Therapeutics Inc (NASDAQ: CMPX) was $4.77 for the day, up 9.91% from the previous closing price of $4.34. In other words, the price has increased by $9.91 from its previous closing price. On the day, 2.07 million shares were traded. CMPX stock price reached its highest trading level at $4.775 during the session, while it also had its lowest trading level at $4.34.
Ratios:
Our analysis of CMPX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.66 and its Current Ratio is at 7.66. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
On April 02, 2025, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform but kept the price unchanged to $6.
On February 24, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.Guggenheim initiated its Buy rating on February 24, 2025, with a $12 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 27 ’25 when Schuetz Thomas J. bought 10,000 shares for $2.11 per share. The transaction valued at 21,100 led to the insider holds 6,480,825 shares of the business.
GORDON CARL L sold 3,571,428 shares of CMPX for $5,678,571 on Apr 09 ’25. The Director now owns 0 shares after completing the transaction at $1.59 per share. On Apr 09 ’25, another insider, ORBIMED ADVISORS LLC, who serves as the Director of the company, sold 3,571,428 shares for $1.59 each. As a result, the insider received 5,678,571 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 818400832 and an Enterprise Value of 568562496.
Stock Price History:
The Beta on a monthly basis for CMPX is 1.26, which has changed by 1.2782152 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, CMPX has reached a high of $4.39, while it has fallen to a 52-week low of $1.27. The 50-Day Moving Average of the stock is 38.75%, while the 200-Day Moving Average is calculated to be 77.54%.
Shares Statistics:
CMPX traded an average of 1.34M shares per day over the past three months and 1761940 shares per day over the past ten days. A total of 138.28M shares are outstanding, with a floating share count of 109.99M. Insiders hold about 35.89% of the company’s shares, while institutions hold 43.14% stake in the company. Shares short for CMPX as of 1759190400 were 14815308 with a Short Ratio of 11.04, compared to 1756425600 on 10251661. Therefore, it implies a Short% of Shares Outstanding of 14815308 and a Short% of Float of 13.939999.
Earnings Estimates
Current recommendations for the stock of the company come from 8.0 analysts. The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.04 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.4 and -$0.6 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.54, with 8.0 analysts recommending between -$0.25 and -$0.76.
